| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | L-serine-phosphatidylethanolamine phosphatidyltransferase activity | 6.91e-06 | 2 | 53 | 2 | GO:0106245 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TMC1 CLCN7 SLC50A1 SLC15A4 PEX2 SLC9A7 GRIA2 ABCC12 ASIC5 ABCA10 ANO3 GABRA2 GABRA3 | 9.19e-06 | 1180 | 53 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | TMC1 CLCN7 SLC50A1 SLC15A4 PEX2 SLC9A7 GRIA2 ABCC12 ASIC5 ABCA10 ANO3 GABRA2 GABRA3 | 2.36e-05 | 1289 | 53 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | phosphotransferase activity, for other substituted phosphate groups | 2.62e-05 | 22 | 53 | 3 | GO:0016780 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.74e-05 | 334 | 53 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.44e-05 | 24 | 53 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | hyaluronan synthase activity | 4.13e-05 | 4 | 53 | 2 | GO:0050501 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.68e-05 | 75 | 53 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 4.94e-05 | 27 | 53 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.99e-05 | 86 | 53 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | taste receptor activity | 9.11e-05 | 33 | 53 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.44e-04 | 100 | 53 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.44e-04 | 7 | 53 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.55e-04 | 758 | 53 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.58e-04 | 193 | 53 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.61e-04 | 103 | 53 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.74e-04 | 197 | 53 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.00e-04 | 459 | 53 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 2.17e-04 | 793 | 53 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 3.17e-04 | 50 | 53 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 3.38e-04 | 125 | 53 | 4 | GO:0015108 | |
| GeneOntologyMolecularFunction | ATP-dependent protein binding | 3.74e-04 | 11 | 53 | 2 | GO:0043008 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 3.74e-04 | 11 | 53 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | channel activity | 4.51e-04 | 525 | 53 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 4.56e-04 | 526 | 53 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.67e-04 | 57 | 53 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5.43e-04 | 60 | 53 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 6.87e-04 | 65 | 53 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 6.87e-04 | 65 | 53 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 6.90e-04 | 151 | 53 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.03e-03 | 18 | 53 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.03e-03 | 18 | 53 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.10e-03 | 171 | 53 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.12e-03 | 77 | 53 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.15e-03 | 19 | 53 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.54e-03 | 22 | 53 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 3.67e-03 | 34 | 53 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 7.13e-03 | 288 | 53 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 7.51e-03 | 49 | 53 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 7.81e-03 | 153 | 53 | 3 | GO:0008194 | |
| GeneOntologyMolecularFunction | sodium channel activity | 8.42e-03 | 52 | 53 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 8.52e-03 | 477 | 53 | 5 | GO:0022804 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 8.68e-03 | 1353 | 53 | 9 | GO:0004888 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.06e-02 | 171 | 53 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.07e-02 | 59 | 53 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.36e-02 | 188 | 53 | 3 | GO:0015078 | |
| GeneOntologyBiologicalProcess | phosphatidylserine biosynthetic process | 3.87e-05 | 4 | 53 | 2 | GO:0006659 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 9.79e-05 | 180 | 53 | 5 | GO:0060078 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TMC1 CLCN7 SLC15A4 WWP1 SLC9A7 GRIA2 ASIC5 MICU2 ANO3 GABRA2 GABRA3 | 1.03e-04 | 1115 | 53 | 11 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TMC1 ZMPSTE24 CLCN7 SLC15A4 WWP1 SLC9A7 GRIA2 ASIC5 MICU2 ANO3 GABRA2 GABRA3 | 1.51e-04 | 1374 | 53 | 12 | GO:0006811 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 1.97e-04 | 112 | 53 | 4 | GO:1902476 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of bitter taste | 1.97e-04 | 44 | 53 | 3 | GO:0001580 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | RAB3GAP1 SGMS2 ZMPSTE24 DNAJC25 SURF4 DHCR7 PTDSS1 DIO1 ABCC12 PTDSS2 EXT2 TMEM39A HAS2 PHTF1 | 3.50e-06 | 1293 | 54 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | RAB3GAP1 SGMS2 ZMPSTE24 DNAJC25 SURF4 DHCR7 PTDSS1 DIO1 ABCC12 PTDSS2 EXT2 TMEM39A HAS2 PHTF1 | 3.70e-06 | 1299 | 54 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RAB3GAP1 SGMS2 ZMPSTE24 DNAJC25 SURF4 DHCR7 PTDSS1 DIO1 ABCC12 PTDSS2 EXT2 TMEM39A HAS2 PHTF1 | 4.74e-06 | 1327 | 54 | 14 | GO:0042175 |
| GeneOntologyCellularComponent | dendrite membrane | 1.32e-05 | 56 | 54 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | neuron projection membrane | 5.99e-05 | 82 | 54 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | chloride channel complex | 4.32e-04 | 57 | 54 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.08e-03 | 78 | 54 | 3 | GO:0048787 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.09e-03 | 19 | 54 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.33e-03 | 21 | 54 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | leading edge membrane | 2.11e-03 | 210 | 54 | 4 | GO:0031256 | |
| Domain | TF_homeodomain_male | 7.90e-06 | 2 | 53 | 2 | IPR021980 | |
| Domain | PSS | 7.90e-06 | 2 | 53 | 2 | IPR004277 | |
| Domain | Phtf-FEM1B_bdg | 7.90e-06 | 2 | 53 | 2 | PF12129 | |
| Domain | PSS | 7.90e-06 | 2 | 53 | 2 | PF03034 | |
| Domain | HAS/NodC | 2.37e-05 | 3 | 53 | 2 | IPR026107 | |
| Domain | - | 8.18e-05 | 81 | 53 | 4 | 3.90.550.10 | |
| Domain | Glyco_trans_2-like | 8.30e-05 | 30 | 53 | 3 | IPR001173 | |
| Domain | Glycos_transf_2 | 8.30e-05 | 30 | 53 | 3 | PF00535 | |
| Domain | Nucleotide-diphossugar_trans | 1.13e-04 | 88 | 53 | 4 | IPR029044 | |
| Domain | GABAAa_rcpt | 1.18e-04 | 6 | 53 | 2 | IPR001390 | |
| Domain | GPCR_kinase | 1.64e-04 | 7 | 53 | 2 | IPR000239 | |
| Domain | GABAA/Glycine_rcpt | 1.92e-03 | 23 | 53 | 2 | IPR006028 | |
| Domain | TAS2R | 2.46e-03 | 26 | 53 | 2 | PF05296 | |
| Domain | T2R | 2.46e-03 | 26 | 53 | 2 | IPR007960 | |
| Domain | RGS | 4.43e-03 | 35 | 53 | 2 | PF00615 | |
| Domain | RGS | 4.43e-03 | 35 | 53 | 2 | SM00315 | |
| Domain | RGS | 4.68e-03 | 36 | 53 | 2 | PS50132 | |
| Domain | RGS | 5.47e-03 | 39 | 53 | 2 | IPR016137 | |
| Domain | ABC_transporter_CS | 6.33e-03 | 42 | 53 | 2 | IPR017871 | |
| Domain | Neurotransmitter_ion_chnl_CS | 7.23e-03 | 45 | 53 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 7.55e-03 | 46 | 53 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 7.87e-03 | 47 | 53 | 2 | PF02931 | |
| Domain | Neur_channel | 7.87e-03 | 47 | 53 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 7.87e-03 | 47 | 53 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 7.87e-03 | 47 | 53 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 7.87e-03 | 47 | 53 | 2 | IPR006029 | |
| Domain | - | 7.87e-03 | 47 | 53 | 2 | 2.70.170.10 | |
| Domain | DnaJ | 8.20e-03 | 48 | 53 | 2 | PF00226 | |
| Domain | ABC_TRANSPORTER_2 | 8.20e-03 | 48 | 53 | 2 | PS50893 | |
| Domain | ABC_tran | 8.20e-03 | 48 | 53 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 8.53e-03 | 49 | 53 | 2 | PS00211 | |
| Domain | DnaJ | 8.53e-03 | 49 | 53 | 2 | SM00271 | |
| Domain | DNAJ_1 | 8.53e-03 | 49 | 53 | 2 | PS00636 | |
| Domain | DNAJ_2 | 8.53e-03 | 49 | 53 | 2 | PS50076 | |
| Domain | - | 8.53e-03 | 49 | 53 | 2 | 1.10.287.110 | |
| Domain | ABC_transporter-like | 8.87e-03 | 50 | 53 | 2 | IPR003439 | |
| Domain | DnaJ_domain | 9.22e-03 | 51 | 53 | 2 | IPR001623 | |
| Domain | AGC-kinase_C | 1.10e-02 | 56 | 53 | 2 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 1.10e-02 | 56 | 53 | 2 | PS51285 | |
| Domain | S_TK_X | 1.10e-02 | 56 | 53 | 2 | SM00133 | |
| Pathway | REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT | 1.08e-04 | 5 | 47 | 2 | MM14865 | |
| Pathway | REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT | 1.08e-04 | 5 | 47 | 2 | M27144 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CLCN7 SLC50A1 LIPG SLC15A4 WWP1 SLC9A7 ASIC5 MICU2 ABCA10 ANO3 | 1.26e-04 | 736 | 47 | 10 | M27287 |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.24e-04 | 99 | 47 | 4 | MM14910 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.55e-04 | 681 | 47 | 9 | MM14985 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 3.86e-04 | 9 | 47 | 2 | M22034 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.20e-04 | 106 | 47 | 4 | M27200 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.81e-04 | 10 | 47 | 2 | MM1401 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 4.81e-04 | 10 | 47 | 2 | M477 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 6.51e-04 | 119 | 47 | 4 | M48309 | |
| Pathway | WP_KENNEDY_PATHWAY | 9.65e-04 | 14 | 47 | 2 | MM15980 | |
| Pathway | WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS | 9.65e-04 | 14 | 47 | 2 | M39620 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 1.43e-03 | 17 | 47 | 2 | M666 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 1.43e-03 | 17 | 47 | 2 | MM14864 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 2.04e-03 | 272 | 47 | 5 | M13380 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 33803805 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18343815 | ||
| Pubmed | Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth. | 2.37e-06 | 2 | 54 | 2 | 22529214 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22763624 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 14766194 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 9016821 | ||
| Pubmed | Molecular and neuronal substrate for the selective attenuation of anxiety. | 2.37e-06 | 2 | 54 | 2 | 11021797 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 27184066 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 10432300 | ||
| Pubmed | Hyaluronic acid, HAS1, and HAS2 are significantly upregulated during muscle hypertrophy. | 2.37e-06 | 2 | 54 | 2 | 22785117 | |
| Pubmed | Phosphatidylserine synthase-1 and -2 are localized to mitochondria-associated membranes. | 2.37e-06 | 2 | 54 | 2 | 10938271 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 26521733 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 24553732 | ||
| Pubmed | Reversal of pathological pain through specific spinal GABAA receptor subtypes. | 2.37e-06 | 2 | 54 | 2 | 18202657 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 23147414 | ||
| Pubmed | Defining the importance of phosphatidylserine synthase 2 in mice. | 2.37e-06 | 2 | 54 | 2 | 12361952 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 22666188 | ||
| Pubmed | Structure and expression of the murine phosphatidylserine synthase-1 gene. | 2.37e-06 | 2 | 54 | 2 | 11084049 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 23067879 | ||
| Pubmed | Enrichment of GABAA Receptor α-Subunits on the Axonal Initial Segment Shows Regional Differences. | 2.37e-06 | 2 | 54 | 2 | 26973458 | |
| Pubmed | Molecular characterization of a novel gene family (PHTF) conserved from Drosophila to mammals. | 2.37e-06 | 2 | 54 | 2 | 10729229 | |
| Pubmed | Purification and characterization of human phosphatidylserine synthases 1 and 2. | 2.37e-06 | 2 | 54 | 2 | 19014349 | |
| Pubmed | Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. | 2.37e-06 | 2 | 54 | 2 | 20823158 | |
| Pubmed | Functional mapping of GABA A receptor subtypes in the amygdala. | 2.37e-06 | 2 | 54 | 2 | 15341600 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8391122 | ||
| Pubmed | Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. | 7.09e-06 | 3 | 54 | 2 | 10455188 | |
| Pubmed | Expression of hyaluronan synthase genes in umbilical cord blood stem/progenitor cells. | 7.09e-06 | 3 | 54 | 2 | 16564133 | |
| Pubmed | Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. | 7.09e-06 | 3 | 54 | 2 | 9442026 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 25325984 | ||
| Pubmed | Mammalian hyaluronan synthases: investigation of functional relationships in vivo. | 7.09e-06 | 3 | 54 | 2 | 10093717 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 19320776 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 24790187 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 16835366 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 1356407 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27289075 | ||
| Pubmed | Perturbation of hyaluronan synthesis in the trabecular meshwork and the effects on outflow facility. | 7.09e-06 | 3 | 54 | 2 | 22695958 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15765504 | ||
| Pubmed | Hyaluronan Modulates the Biomechanical Properties of the Cornea. | 7.09e-06 | 3 | 54 | 2 | 36478198 | |
| Pubmed | Hyaluronan Regulates Eyelid and Meibomian Gland Morphogenesis. | 7.09e-06 | 3 | 54 | 2 | 30046813 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 16786194 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 25795779 | ||
| Pubmed | Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3. | 7.09e-06 | 3 | 54 | 2 | 23303191 | |
| Pubmed | Hyaluronan Derived From the Limbus is a Key Regulator of Corneal Lymphangiogenesis. | 7.09e-06 | 3 | 54 | 2 | 30897620 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 27128218 | ||
| Pubmed | Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome. | 7.09e-06 | 3 | 54 | 2 | 30614308 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 22654110 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 11790779 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 10617644 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15017002 | ||
| Pubmed | Involvement of hyaluronan in regulation of fibroblast phenotype. | 7.09e-06 | 3 | 54 | 2 | 17611197 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 20960509 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 9206724 | ||
| Pubmed | Expression regulation of hyaluronan synthase in corneal endothelial cells. | 7.09e-06 | 3 | 54 | 2 | 11006212 | |
| Pubmed | Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes. | 7.09e-06 | 3 | 54 | 2 | 24057227 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 15304513 | ||
| Pubmed | Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. | 7.09e-06 | 3 | 54 | 2 | 11431361 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | 7.84e-06 | 468 | 54 | 7 | 31056421 | |
| Pubmed | 7.90e-06 | 81 | 54 | 4 | 22723691 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 10379886 | ||
| Pubmed | Hyaluronan in cervical epithelia protects against infection-mediated preterm birth. | 1.42e-05 | 4 | 54 | 2 | 25384213 | |
| Pubmed | Dynamic states of cervical epithelia during pregnancy and epithelial barrier disruption. | 1.42e-05 | 4 | 54 | 2 | 36718364 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 23560496 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 9457904 | ||
| Pubmed | Prelamin A causes aberrant myonuclear arrangement and results in muscle fiber weakness. | 1.42e-05 | 4 | 54 | 2 | 30282816 | |
| Pubmed | The control and importance of hyaluronan synthase expression in palatogenesis. | 1.42e-05 | 4 | 54 | 2 | 23382716 | |
| Pubmed | Association study between GABA receptor genes and anxiety spectrum disorders. | 1.42e-05 | 4 | 54 | 2 | 19842164 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 25865415 | ||
| Pubmed | Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury. | 1.42e-05 | 4 | 54 | 2 | 15854028 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 26518133 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 28863216 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 20072653 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 25080596 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 14636845 | ||
| Pubmed | Nitric oxide alters hyaluronan deposition by airway smooth muscle cells. | 1.42e-05 | 4 | 54 | 2 | 29966020 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 1.42e-05 | 4 | 54 | 2 | 18821008 | |
| Pubmed | 1.46e-05 | 952 | 54 | 9 | 38569033 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 19435493 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 20875124 | ||
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 2.36e-05 | 5 | 54 | 2 | 30104684 | |
| Pubmed | A pericellular hyaluronan matrix is required for the morphological maturation of cortical neurons. | 2.36e-05 | 5 | 54 | 2 | 32623025 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 3.43e-05 | 1061 | 54 | 9 | 33845483 | |
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 20457185 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 3.54e-05 | 6 | 54 | 2 | 15033447 | |
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 19577615 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 10506199 | ||
| Pubmed | FGF9 Promotes Expression of HAS2 in Palatal Elevation via the Wnt/β-Catenin/TCF7L2 Pathway. | 3.54e-05 | 6 | 54 | 2 | 36358989 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 8672451 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 26518873 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 7560270 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 4.94e-05 | 7 | 54 | 2 | 20843900 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 35228700 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 11517230 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 16101898 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 8175718 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 17324121 | ||
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 11528422 | ||
| Pubmed | 7.39e-05 | 143 | 54 | 4 | 20424473 | ||
| Pubmed | Loss of postsynaptic GABA(A) receptor clustering in gephyrin-deficient mice. | 8.46e-05 | 9 | 54 | 2 | 10531433 | |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 1.06e-04 | 10 | 54 | 2 | 11435397 | |
| Pubmed | 1.06e-04 | 10 | 54 | 2 | 36733270 | ||
| Interaction | DNAJC25 interactions | 9.08e-06 | 284 | 53 | 7 | int:DNAJC25 | |
| Interaction | SEC61B interactions | FREM2 RAB3GAP1 ZMPSTE24 CLCN7 DNAJC25 SURF4 DHCR7 SUN1 NEMF PTDSS1 | 2.54e-05 | 763 | 53 | 10 | int:SEC61B |
| Interaction | TCTN3 interactions | 2.58e-05 | 334 | 53 | 7 | int:TCTN3 | |
| Interaction | LNPK interactions | 3.81e-05 | 355 | 53 | 7 | int:LNPK | |
| Interaction | GRAMD1B interactions | 4.51e-05 | 75 | 53 | 4 | int:GRAMD1B | |
| Interaction | SEC62 interactions | 4.91e-05 | 506 | 53 | 8 | int:SEC62 | |
| Interaction | VAPA interactions | 6.75e-05 | 686 | 53 | 9 | int:VAPA | |
| Cytoband | 4q32.1 | 4.18e-04 | 26 | 53 | 2 | 4q32.1 | |
| GeneFamily | Glycosyltransferase family 2 | 6.08e-05 | 6 | 37 | 2 | 428 | |
| GeneFamily | Taste 2 receptors | 6.85e-05 | 39 | 37 | 3 | 1162 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 6.82e-04 | 19 | 37 | 2 | 563 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.51e-03 | 49 | 37 | 2 | 584 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.95e-06 | 188 | 53 | 5 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.39e-05 | 154 | 53 | 4 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-05 | 161 | 53 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-05 | 164 | 53 | 4 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.10e-05 | 171 | 53 | 4 | f648789e6aefe508bb748401bf9b3cd830fb0ddf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_LCN15|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.10e-05 | 171 | 53 | 4 | 6a489a75eeab2a2d48d604682e93599c20a945fe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.58e-05 | 175 | 53 | 4 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-5|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.96e-05 | 178 | 53 | 4 | ad5cd505ca1cef8ac29b2af7e2c3e01ebc140c14 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-05 | 179 | 53 | 4 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.64e-05 | 183 | 53 | 4 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 64bcdbb422f8da6fc3275e82f6aaf562f546a180 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | aaa5042388dc451bff384c6bb237348f08280a08 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 4aee372ba2c0351b0221d0d468707d1ad21526d6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.15e-05 | 193 | 53 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-05 | 193 | 53 | 4 | 5a92697430f16c49e19a5f727d289d7bd1ece31c | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.32e-05 | 194 | 53 | 4 | 4428b472c2042f88eae028b1770767512a515b75 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-05 | 199 | 53 | 4 | 08c7e631b2e203dd7dcb75a7f9377d292bc5a0fd | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-05 | 199 | 53 | 4 | 4338bf6cafc26c5d6497955d91914f84bacfacfa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | be83f442179ba4217d12f0458059586ff3130991 | |
| Computational | Genes in the cancer module 396. | 3.38e-04 | 12 | 25 | 2 | MODULE_396 | |
| Drug | Secobarbital | 1.41e-06 | 10 | 53 | 3 | DB00418 | |
| Drug | Metharbital | 1.41e-06 | 10 | 53 | 3 | DB00463 | |
| Drug | Pentobarbital | 1.41e-06 | 10 | 53 | 3 | DB00312 | |
| Drug | Talbutal | 1.41e-06 | 10 | 53 | 3 | DB00306 | |
| Drug | Butalbital | 1.41e-06 | 10 | 53 | 3 | DB00241 | |
| Drug | Butabarbital | 1.41e-06 | 10 | 53 | 3 | DB00237 | |
| Drug | Barbituric acid derivative | 1.41e-06 | 10 | 53 | 3 | DB01496 | |
| Drug | Barbital | 1.41e-06 | 10 | 53 | 3 | DB01483 | |
| Drug | Hexobarbital | 1.41e-06 | 10 | 53 | 3 | DB01355 | |
| Drug | Aprobarbital | 1.41e-06 | 10 | 53 | 3 | DB01352 | |
| Drug | Amobarbital | 1.41e-06 | 10 | 53 | 3 | DB01351 | |
| Drug | Heptabarbital | 1.41e-06 | 10 | 53 | 3 | DB01354 | |
| Drug | Butethal | 1.41e-06 | 10 | 53 | 3 | DB01353 | |
| Drug | Methylphenobarbital | 1.41e-06 | 10 | 53 | 3 | DB00849 | |
| Drug | Primidone | 1.41e-06 | 10 | 53 | 3 | DB00794 | |
| Drug | Thiopental | 1.94e-06 | 11 | 53 | 3 | DB00599 | |
| Drug | Phenobarbital | 1.94e-06 | 11 | 53 | 3 | DB01174 | |
| Drug | Zolpidem | 1.59e-05 | 3 | 53 | 2 | DB00425 | |
| Drug | Flumazenil | 3.18e-05 | 4 | 53 | 2 | DB01205 | |
| Drug | etizolam | 3.18e-05 | 4 | 53 | 2 | ctd:C044610 | |
| Drug | Eszopiclone | 5.29e-05 | 5 | 53 | 2 | DB00402 | |
| Drug | Quinidine barbiturate | 5.29e-05 | 5 | 53 | 2 | DB01346 | |
| Drug | Zopiclone | 5.29e-05 | 5 | 53 | 2 | DB01198 | |
| Drug | Lorazepam | 5.29e-05 | 5 | 53 | 2 | ctd:D008140 | |
| Drug | Tn 5 | 6.00e-05 | 179 | 53 | 5 | CID006852148 | |
| Drug | picrotoxin | 6.33e-05 | 181 | 53 | 5 | CID000031304 | |
| Drug | Meprobamate | 7.93e-05 | 6 | 53 | 2 | DB00371 | |
| Drug | Flunitrazepam | 7.93e-05 | 6 | 53 | 2 | DB01544 | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 8.36e-05 | 192 | 53 | 5 | 6013_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A | 8.36e-05 | 192 | 53 | 5 | 1929_DN | |
| Drug | Paclitaxel [33069-62-4]; Down 200; 4.6uM; PC3; HG-U133A | 9.22e-05 | 196 | 53 | 5 | 1959_DN | |
| Drug | Quazepam | 1.11e-04 | 7 | 53 | 2 | DB01589 | |
| Drug | Adinazolam | 1.48e-04 | 8 | 53 | 2 | DB00546 | |
| Drug | Fludiazepam | 1.48e-04 | 8 | 53 | 2 | DB01567 | |
| Drug | Clotiazepam | 1.48e-04 | 8 | 53 | 2 | DB01559 | |
| Drug | Cinolazepam | 1.48e-04 | 8 | 53 | 2 | DB01594 | |
| Drug | Prazepam | 1.48e-04 | 8 | 53 | 2 | DB01588 | |
| Drug | Estazolam | 1.48e-04 | 8 | 53 | 2 | DB01215 | |
| Drug | Halazepam | 1.48e-04 | 8 | 53 | 2 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 1.48e-04 | 8 | 53 | 2 | ctd:C091518 | |
| Drug | tiotidine | 1.89e-04 | 9 | 53 | 2 | ctd:C023990 | |
| Drug | Ethchlorvynol | 1.89e-04 | 9 | 53 | 2 | DB00189 | |
| Drug | Diazepam | 1.89e-04 | 9 | 53 | 2 | DB00829 | |
| Drug | Chlordiazepoxide | 2.36e-04 | 10 | 53 | 2 | DB00475 | |
| Drug | Clobazam | 2.36e-04 | 10 | 53 | 2 | DB00349 | |
| Drug | Bromazepam | 2.36e-04 | 10 | 53 | 2 | DB01558 | |
| Drug | Phosphatidylserine | 2.36e-04 | 10 | 53 | 2 | DB00144 | |
| Drug | R396 | 2.36e-04 | 10 | 53 | 2 | CID000164286 | |
| Drug | Clonazepam | 2.36e-04 | 10 | 53 | 2 | DB01068 | |
| Drug | R 487 | 2.36e-04 | 10 | 53 | 2 | CID000131469 | |
| Drug | Oxazepam | 2.36e-04 | 10 | 53 | 2 | DB00842 | |
| Drug | Midazolam | 2.36e-04 | 10 | 53 | 2 | DB00683 | |
| Drug | Flurazepam | 2.36e-04 | 10 | 53 | 2 | DB00690 | |
| Drug | pentylenetetrazol | 2.39e-04 | 130 | 53 | 4 | CID000005917 | |
| Drug | oxazepam | 2.57e-04 | 53 | 53 | 3 | CID000004616 | |
| Drug | Alprazolam | 2.89e-04 | 11 | 53 | 2 | DB00404 | |
| Drug | Temazepam | 2.89e-04 | 11 | 53 | 2 | DB00231 | |
| Drug | Nitrazepam | 2.89e-04 | 11 | 53 | 2 | DB01595 | |
| Drug | Lorazepam | 2.89e-04 | 11 | 53 | 2 | DB00186 | |
| Drug | Musk T | 2.89e-04 | 11 | 53 | 2 | CID000061014 | |
| Drug | Triazolam | 2.89e-04 | 11 | 53 | 2 | DB00897 | |
| Drug | Clorazepate | 2.89e-04 | 11 | 53 | 2 | DB00628 | |
| Drug | NSC46155 | 3.46e-04 | 12 | 53 | 2 | CID000457869 | |
| Drug | ketamine | 3.55e-04 | 262 | 53 | 5 | CID000003821 | |
| Disease | Autistic Disorder | 1.16e-03 | 261 | 52 | 4 | C0004352 | |
| Disease | Cocaine-Related Disorders | 1.17e-03 | 117 | 52 | 3 | C0236736 | |
| Disease | Cocaine Abuse | 1.48e-03 | 127 | 52 | 3 | C0009171 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FISWYSSFGFVRRWN | 241 | P51689 | |
| FIFRKWRKNNGFWSF | 1036 | Q8WWZ4 | |
| ANTTYRLQWWDFTKF | 856 | Q9C0C7 | |
| VIDFFWNETWYLKTI | 281 | Q9UBM7 | |
| SFKWNFIKQYWQFAT | 581 | Q9BYT9 | |
| FYLKQWRSYNISIWD | 41 | Q9NX57 | |
| RFTYVLQDWQQYFWP | 231 | Q15042 | |
| WFEKFLWFISSENYL | 526 | O60524 | |
| YQNFRLNWAWISFEK | 1761 | Q5SZK8 | |
| FATVNYFTKRGWAWD | 331 | P47869 | |
| ASFWNQFLTWRIFFA | 316 | P51798 | |
| WWFFTLIIISSYTAN | 626 | P42262 | |
| WVFLWRFTIYSKNAT | 61 | P28328 | |
| QSWYNLWKEFRSYLS | 421 | Q9Y5X9 | |
| FATVNYFTKRSWAWE | 356 | P34903 | |
| NTYFVLSSWWAKALF | 96 | Q9H3Z4 | |
| WIPTFFSTQYFWFVL | 61 | P49895 | |
| FSTQYFWFVLKVRWQ | 66 | P49895 | |
| VFQFFSWWNSYNKAI | 161 | Q9H1X3 | |
| QTRWSKSYFREWLYN | 351 | Q92819 | |
| FDWNLQFKWDNVFSY | 276 | Q7Z4T8 | |
| ITSFQGFLIFIWYWS | 646 | Q9Y653 | |
| VTWQIYIRLLNYFTW | 76 | Q9NY37 | |
| WVSFLSSLRYWVAFN | 276 | Q92839 | |
| QTRWSKSYFREWLYN | 376 | Q92839 | |
| KRSWVWNQFFVLEEY | 46 | Q9ULB5 | |
| SYFSQFLQWKWLERQ | 166 | P32298 | |
| YLDSIYFNRFLQWKW | 161 | P43250 | |
| WQKLWVVFTNFCLFF | 946 | O94887 | |
| FSWTVYLWETFLAQR | 26 | O75844 | |
| TRRFFNWFYWSINLG | 191 | Q8N697 | |
| KSVWYRIAFWLQWFN | 336 | Q9H3N8 | |
| LKQTFLSVFWQVRYW | 286 | P0DSN6 | |
| FFPFFFRWWLQVTSK | 121 | Q8N3S3 | |
| IAFQFTPYSWVRFEW | 291 | Q9BVG9 | |
| WLLFFTNTENKDIYW | 286 | Q8IYU8 | |
| WLFAINVYFNAFWTI | 211 | O15260 | |
| WWKTGIAFIYAVFNL | 76 | Q8NHU3 | |
| RAWWFPIFYFFEKNV | 311 | Q8NHU3 | |
| WKYIQQVYLASFWLA | 331 | P29371 | |
| KVFFWALAWAINYRT | 176 | Q96J65 | |
| ATWVFVATWYRVTFF | 146 | Q8TER0 | |
| FNFSWKVFTSWDYLI | 311 | Q8TDI8 | |
| SFREWIRKFNWSSYN | 31 | Q9NYW4 | |
| WIEQSVFRQWFEKYF | 256 | Q4W5G0 | |
| KTFLNDAYNWEFLIW | 636 | Q9UMS5 | |
| VFSNWAQFWLTMFYL | 131 | Q96N76 | |
| ALFIQYINIYKTVWW | 86 | Q9NV64 | |
| VTSFIRFWLFWKYPQ | 196 | Q9BRV3 | |
| QARWFWEAYFQSIKA | 391 | Q93063 | |
| FTFWTFANYLNMWIT | 86 | Q9NYW2 | |
| GWYQFVTLISWLNVF | 266 | O94901 | |
| QLSTSFQWVTKWVDY | 496 | Q9NYY3 | |
| IYSKQSVFFVWELKW | 1001 | P48553 | |
| YTRNSKQIIWFWQFV | 821 | Q9H0M0 | |
| KQESAWIFRLWYSFD | 591 | Q96T83 | |
| SWTYVRWFDPKSSFQ | 271 | P48651 |